Nicola Normanno

32.3k total citations · 7 hit papers
362 papers, 18.5k citations indexed

About

Nicola Normanno is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Nicola Normanno has authored 362 papers receiving a total of 18.5k indexed citations (citations by other indexed papers that have themselves been cited), including 247 papers in Oncology, 163 papers in Pulmonary and Respiratory Medicine and 125 papers in Cancer Research. Recurrent topics in Nicola Normanno's work include Lung Cancer Treatments and Mutations (124 papers), Cancer Genomics and Diagnostics (107 papers) and Colorectal Cancer Treatments and Studies (100 papers). Nicola Normanno is often cited by papers focused on Lung Cancer Treatments and Mutations (124 papers), Cancer Genomics and Diagnostics (107 papers) and Colorectal Cancer Treatments and Studies (100 papers). Nicola Normanno collaborates with scholars based in Italy, United States and United Kingdom. Nicola Normanno's co-authors include Fortunato Ciardiello, Antonella De Luca, David S. Salomon, Ralf Brandt, Monica R. Maiello, Caterina Bianco, Luigi Strizzi, Mario Mancino, Amelia D’Alessio and David Salomon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Nicola Normanno

353 papers receiving 18.2k citations

Hit Papers

Epidermal growth factor-related peptides and their recept... 1995 2026 2005 2015 1995 2005 2022 2012 2022 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Epidermal growth factor-related peptides and their receptors in human malignancies
    1995 2.2k citations David S. Salomon, Ralf Brandt et al. Critical Reviews in Oncology/Hematology profile →
  2. Epidermal growth factor receptor (EGFR) signaling in cancer
    2005 1.6k citations Nicola Normanno, Antonella De Luca et al. Gene profile →
  3. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    2022 774 citations Andrés Cervantes, R. Adam et al. Annals of Oncology profile →
  4. The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
    2012 581 citations Antonella De Luca, Monica R. Maiello et al. profile →
  5. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
    2022 355 citations Nicola Normanno, Takayuki Yoshino et al. Annals of Oncology profile →
  6. Implementing TMB measurement in clinical practice: considerations on assay requirements
    2019 247 citations Fernando López‐Ríos, Nicola Normanno et al. profile →
  7. Delivering precision oncology to patients with cancer
    2022 197 citations Nicola Normanno et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicola Normanno Italy 63 10.5k 8.4k 5.6k 4.5k 2.2k 362 18.5k
Patricia LoRusso United States 69 11.2k 1.1× 10.9k 1.3× 4.4k 0.8× 2.8k 0.6× 2.0k 0.9× 569 21.9k
Kazuto Nishio Japan 69 8.0k 0.8× 7.6k 0.9× 6.2k 1.1× 3.5k 0.8× 1.5k 0.7× 532 16.2k
Jeff Settleman United States 38 10.8k 1.0× 10.6k 1.3× 8.5k 1.5× 5.1k 1.1× 1.5k 0.7× 66 20.5k
John Crown Ireland 71 13.0k 1.2× 7.4k 0.9× 4.8k 0.9× 6.0k 1.3× 1.2k 0.5× 416 20.1k
Bryan T. Hennessy Ireland 59 9.0k 0.9× 9.7k 1.2× 3.0k 0.5× 6.4k 1.4× 3.1k 1.4× 266 19.8k
William Novotny United States 38 12.5k 1.2× 8.0k 1.0× 5.7k 1.0× 3.8k 0.8× 2.2k 1.0× 110 22.6k
Naoto T. Ueno United States 72 11.0k 1.1× 5.6k 0.7× 3.7k 0.7× 6.5k 1.4× 2.2k 1.0× 547 20.4k
Stan B. Kaye United Kingdom 65 9.5k 0.9× 8.7k 1.0× 4.2k 0.7× 3.6k 0.8× 1.6k 0.7× 217 19.2k
Titus J. Boggon United States 46 8.5k 0.8× 9.6k 1.1× 8.9k 1.6× 3.7k 0.8× 1.1k 0.5× 128 19.1k
Michael J. Duffy Ireland 77 8.0k 0.8× 9.0k 1.1× 2.8k 0.5× 7.0k 1.5× 1.5k 0.7× 264 19.1k

Countries citing papers authored by Nicola Normanno

Since Specialization
Citations

This map shows the geographic impact of Nicola Normanno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Normanno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Normanno more than expected).

Fields of papers citing papers by Nicola Normanno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola Normanno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Normanno. The network helps show where Nicola Normanno may publish in the future.

Co-authorship network of co-authors of Nicola Normanno

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola Normanno. A scholar is included among the top collaborators of Nicola Normanno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola Normanno. Nicola Normanno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piccinini, Filippo, Jae‐Chul Pyun, Misu Lee, et al.. (2025). ColorI-DT: An open-source tool for the quantitative evaluation of differences in microscopy color images. Computational and Structural Biotechnology Journal. 27. 2526–2536.
2.
Hofman, Paul, Petros Christopoulos, Nicky D’Haene, et al.. (2025). Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancer. Lung Cancer. 201. 108107–108107. 1 indexed citations
3.
Fassan, Matteo, Valentina Angerilli, Nicola Normanno, et al.. (2024). Practical guidelines for molecular testing of cholangiocarcinoma in clinical practice: Italian experts’ position paper. Critical Reviews in Oncology/Hematology. 194. 104224–104224. 8 indexed citations
4.
Angerilli, Valentina, Rossana Intini, Francesca Bergamo, et al.. (2024). Detecting BRAF mutations in colorectal cancer in clinical practice: An Italian experts' position paper. Critical Reviews in Oncology/Hematology. 206. 104574–104574. 3 indexed citations
5.
6.
Granata, Vincenza, Roberta Fusco, Maria Chiara Brunese, et al.. (2024). Machine Learning and Radiomics Analysis for Tumor Budding Prediction in Colorectal Liver Metastases Magnetic Resonance Imaging Assessment. Diagnostics. 14(2). 152–152. 5 indexed citations
7.
Normanno, Nicola, et al.. (2024). Enzyme-Assisted Electrochemical Point-of-Care Test for miRNA Detection in Liquid Biopsy. Analytical Chemistry. 96(49). 19202–19206. 7 indexed citations
8.
Martini, Giulia, Davide Ciardiello, Stefania Napolitano, et al.. (2023). Efficacy and safety of a biomarker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RAS/BRAF wild type tumors at start of first line: The CAPRI 2 GOIM trial. Frontiers in Oncology. 13. 1069370–1069370. 8 indexed citations
9.
Penault‐Llorca, Frédérique, Keith M. Kerr, Pilar Garrido, et al.. (2022). Expert opinion on NSCLC small specimen biomarker testing — Part 1: Tissue collection and management. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(3). 335–350. 29 indexed citations
10.
Cervantes, Andrés, R. Adam, Susana Roselló, et al.. (2022). Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology. 34(1). 10–32. 774 indexed citations breakdown →
11.
Giacò, Luciano, Fernando Palluzzi, Davide Guido, et al.. (2022). A Computational Framework for Comprehensive Genomic Profiling in Solid Cancers: The Analytical Performance of a High-Throughput Assay for Small and Copy Number Variants. Cancers. 14(24). 6152–6152. 6 indexed citations
12.
Liu, Yang, Sen Yang, Jiuzhou Zhao, et al.. (2021). Cell-free DNA from cerebrospinal fluid can be used to detect the EGFR mutation status of lung adenocarcinoma patients with central nervous system metastasis. Translational Lung Cancer Research. 10(2). 914–925. 15 indexed citations
13.
14.
Falcone, Francesca, Nicola Normanno, Simona Losito, et al.. (2019). Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series. European Journal of Obstetrics & Gynecology and Reproductive Biology. 240. 220–225. 36 indexed citations
15.
Luca, Antonella De, Marianna Gallo, Monica R. Maiello, et al.. (2008). Zoledronic acid affects the expression of VEGF in breast cancer cells and in bone marrow stromal cells through direct and indirect mechanisms. Cancer Research. 68. 294–294. 1 indexed citations
16.
Normanno, Nicola, Manuela Campiglio, Monica R. Maiello, et al.. (2007). Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signaling. Breast Cancer Research and Treatment. 112(1). 25–33. 42 indexed citations
17.
Normanno, Nicola, Antonella De Luca, Caterina Bianco, et al.. (2005). Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 366(1). 2–16. 1576 indexed citations breakdown →
18.
Normanno, Nicola, Monica R. Maiello, & Antonella De Luca. (2002). Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs): Simple drugs with a complex mechanism of action?. Journal of Cellular Physiology. 194(1). 13–19. 118 indexed citations
19.
Normanno, Nicola, Fortunato Ciardiello, Ralf Brandt, & David S. Salomon. (1994). Epidermal growth factor-related peptides in the pathogenesis of human breast cancer. Breast Cancer Research and Treatment. 29(1). 11–27. 90 indexed citations
20.
Ciardiello, Fortunato, Marco M. Gottardis, Fulvio Basolo, et al.. (1992). Additive effects of c‐erbB‐2, c‐Ha‐ras, and transforming growth factor‐α genes on in vitro transformation of human mammary epithelial cells. Molecular Carcinogenesis. 6(1). 43–52. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia LoRusso Breakdown of academic impact, for papers by Kazuto Nishio Breakdown of academic impact, for papers by Jeff Settleman Breakdown of academic impact, for papers by John Crown Breakdown of academic impact, for papers by Bryan T. Hennessy Breakdown of academic impact, for papers by William Novotny Breakdown of academic impact, for papers by Naoto T. Ueno Breakdown of academic impact, for papers by Stan B. Kaye Breakdown of academic impact, for papers by Titus J. Boggon Breakdown of academic impact, for papers by Michael J. Duffy
Rankless by CCL
2026